Monday, July 6, 2026

Unlocking the Hidden Power of Noncoding RNA in Cancer Research

🎤 Founder & CEO Anyou Wang

🏛 DIFIBER LLC, United States

🎙 Keynote Presentation

Presentation Title

Deep systems insights into the conceptual breakthrough of the noncoding RNA functional network and its role in cancer

Event

2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026)




🔬 Redefining Cancer Biology Through Artificial Intelligence

Advances in computational biology, big data, and artificial intelligence are transforming our understanding of cancer. At ICPOC 2026, Dr. Anyou Wang will present groundbreaking research that challenges the traditional protein-centric view of biology by revealing the critical role of noncoding RNAs (ncRNAs) in cancer development and progression.

His research demonstrates how ncRNAs function as powerful endogenous regulators and highlights their universal significance across multiple cancer types.


🔍 Key Highlights

Discovery of the functional network of noncoding RNAs (ncRNAs)

AI-powered analysis of large-scale biological datasets

Computational biology approaches for cancer research

Systems-level understanding of cancer biology

ncRNAs as key regulators in tumor development

Cancer genomics and precision oncology

Evolutionary insights into disease mechanisms

Future applications of AI in personalized cancer care

This keynote offers a new perspective on cancer biology and illustrates how artificial intelligence is accelerating discoveries that may shape the future of precision medicine.


👨🔬 About the Speaker

Dr. Anyou Wang is the Founder and CEO of DIFIBER LLC, United States, and a leading scientist in computational biology, artificial intelligence, and big data analytics.

Career Highlights

🏆 Founder & CEO, DIFIBER LLC

🏆 Graduate of the University of California, Riverside

🏆 Pioneer in computational biology and AI-driven biomedical research

🏆 Discovered the unique functional system of noncoding RNAs

🏆 Demonstrated the central role of ncRNAs across multiple cancers

🏆 Developed computational algorithms to study SARS-CoV-2 evolution

🏆 Research interests include AI, genomics, precision medicine, and systems biology

His innovative work is reshaping the understanding of molecular biology and opening new avenues for cancer diagnosis and treatment.


🌍 Join ICPOC 2026

Be part of a global forum where experts explore the latest advances in cancer research, genomics, artificial intelligence, and precision oncology.

📅 November 23–25, 2026

📍 Singapore & Online

🌐 Official Website
https://cancer.miconferences.com/

📝 Register
https://cancer.miconferences.com/register

📄 Submit Abstract
https://cancer.miconferences.com/abstract-submission

#ICPOC2026 #CancerResearch #ArtificialIntelligence #ComputationalBiology #NoncodingRNA #CancerGenomics #PrecisionMedicine #CancerInnovation #OncologyConference

Unlocking the Hidden Power of Noncoding RNA in Cancer Research

🎤 Founder & CEO Anyou Wang 🏛 DIFIBER LLC, United States 🎙 Keynote Presentation Presentation Title Deep systems insights into...